Topics:
Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Yale • NCI-CCC Breast Tumor Board Question • Breast Cancer, Metastatic
How do you incorporate ctDNA in the management of metastatic breast cancer?
Answer from: Medical Oncologist at Academic Institution
I do use ctDNA molecular profiling assays to detect actionable mutations or for trial matching fairly regularly in my metastatic patients. As for ctDNA tracking tests like Signatera, I would consider their use mainly when routine in-house tumor markers like CA15-3, 27-29, CEA do not correlate well w...
Sign in or Register to read more